Novo Nordisk A/S
Long
Updated

$NVO expected have better second half (H2)

1 087
- Potential Inverse H&S on daily?
- In the worst case, NVO goes to 200 monthly moving average around $36
- Nonetheless, We are bottoming fundamentally only question is how fast the turn around gonna be.
Note
- I had a very big position starting this year and but sold pre-earning when they unprofessionally released earnings on breakeven.

- I have bought back around 43.xx but not gonna build a massive position this time because I am afraid that turn around might be slower.
Note
- There are blood in the streets so I want to build bigger position in other companies where turn around could be faster. However, I am buying NVO for long term as weightloss and well being is multi year secular trend
Note
- NVO will still have better second half where it recovers.
- However, it's clear LLY is a superior drug and NVO latest results confirm it
Trade closed: stop reached
Note
pre-market $42 ; I believe this is heading to 200 day monthly moving average around $36 and then might find support or bottom based on fundamentals
Note
pre-market $42 ; I believe this is heading to 200 day monthly moving average around $36 and then might find support or bottom based on fundamentals
Note
NVO as I mentioned probably has bottomed around 200 day monthly average around 35-36 bucks

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.